Choline PET/CT for prostate cancer: main clinical applications
- PMID: 20800404
- DOI: 10.1016/j.ejrad.2010.07.023
Choline PET/CT for prostate cancer: main clinical applications
Abstract
Several studies investigated the potential roles of imaging modalities in prostate cancer patients for the evaluation of intra-prostatic disease, stage and restage. However no precise guidelines exist about the use of imaging modalities, in particular about the role of PET/CT hybrid imaging. Considering the results of the literature and our experience, we tried to summarize the main applications of choline positron emission tomography (PET) in prostate cancer patients. The use of choline PET/CT for initial diagnosis and staging is not recommended as a first-line method. Instead the main and important application of choline PET/CT is represented by the restaging of the disease in case of biochemical relapse for the detection of lymph node and distant recurrence. In particular choline PET/CT could play a crucial role as first diagnostic procedure in prostate cancer patients who show a fast growing Prostate Specific Antigen (PSA) kinetics.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Impact of 18F-choline PET/CT in prostate cancer patients with biochemical recurrence: influence of androgen deprivation therapy and correlation with PSA kinetics.J Nucl Med. 2013 Jun;54(6):833-40. doi: 10.2967/jnumed.112.110148. Epub 2013 Apr 4. J Nucl Med. 2013. PMID: 23559588 Clinical Trial.
-
Choline PET/CT for imaging prostate cancer: an update.Ann Nucl Med. 2013 Aug;27(7):581-91. doi: 10.1007/s12149-013-0731-7. Epub 2013 Apr 30. Ann Nucl Med. 2013. PMID: 23632880 Review.
-
[Diagnostic relevance of choline-PET / CT in patients with prostate cancer].Aktuelle Urol. 2012 Jan;43(1):49-54. doi: 10.1055/s-0031-1271553. Epub 2011 Jul 18. Aktuelle Urol. 2012. PMID: 21769763 Review. German.
-
Early biochemical relapse after radical prostatectomy: which prostate cancer patients may benefit from a restaging 11C-Choline PET/CT scan before salvage radiation therapy?J Nucl Med. 2014 Sep;55(9):1424-9. doi: 10.2967/jnumed.114.138313. Epub 2014 Jun 16. J Nucl Med. 2014. PMID: 24935990
-
[18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.BJU Int. 2012 Dec;110(11):1666-71. doi: 10.1111/j.1464-410X.2012.11150.x. Epub 2012 Apr 23. BJU Int. 2012. PMID: 22520686
Cited by
-
Individualized image-based lymph node irradiation for prostate cancer.Nat Rev Urol. 2013 Jul;10(7):376-85. doi: 10.1038/nrurol.2013.111. Epub 2013 May 28. Nat Rev Urol. 2013. PMID: 23712209 Review.
-
Diagnostic performance of choline PET/CT for the detection of bone metastasis in prostate cancer: A systematic review and meta-analysis.PLoS One. 2018 Sep 7;13(9):e0203400. doi: 10.1371/journal.pone.0203400. eCollection 2018. PLoS One. 2018. PMID: 30192819 Free PMC article.
-
Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial.Eur J Nucl Med Mol Imaging. 2014 Dec;41(12):2222-31. doi: 10.1007/s00259-014-2872-x. Epub 2014 Aug 15. Eur J Nucl Med Mol Imaging. 2014. PMID: 25182750
-
PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer.Mol Imaging Biol. 2016 Jun;18(3):411-9. doi: 10.1007/s11307-016-0957-6. Mol Imaging Biol. 2016. PMID: 27080322 Free PMC article. Clinical Trial.
-
Head-to-head comparisons of [68Ga]Ga-PSMA-11 PET/CT, multiparametric MRI, and prostate-specific antigen for the evaluation of therapeutic responses to neoadjuvant chemohormonal therapy in high-risk non-metastatic prostate cancer patients: a prospective study.Eur J Nucl Med Mol Imaging. 2023 Mar;50(4):1240-1251. doi: 10.1007/s00259-022-06047-6. Epub 2022 Nov 22. Eur J Nucl Med Mol Imaging. 2023. PMID: 36416906
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous